Zeev, BPRX patent lawsuit is regarding their 40%-urea dermatologic
compositions, which per DJ news today
"are the key component in a Bradley product line that accounted for 54% of the company's 2002 revenue".
Is it possible the market is taking this as though BPRX could lose 50% of their rev's?
Hard to think BPRX would fall this far due to pure uncertainty.
Although, in this crazy market, nothing surprises me anymore.
Also, BTW, notice NOVN is continuing to print new lows ... hit 7.30 today. Where would you be a buyer?